| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 3956802 | Journal of Minimally Invasive Gynecology | 2010 | 7 Pages | 
Abstract
												Misoprostol, a prostaglandin E1 derivative, has been widely used in nonpregnant women because of its cervical ripening and uterotonic effects. A large number of studies have demonstrated its effectiveness in enhancing ease of cervical dilation. This review article describes its pharmacokinetic profile and the relationship between prostaglandins and cervical ripening and uterine contraction and provides a review of the clinical use of misoprostol in nonpregnant women including cervical priming before hysteroscopy, before insertion of an intrauterine device, in endometrium biopsy, preoperatively in myomectomy, and before intrauterine insemination to improve pregnancy rates. Adverse effects are also described.
Keywords
												
											Related Topics
												
													Health Sciences
													Medicine and Dentistry
													Obstetrics, Gynecology and Women's Health
												
											Authors
												Chainarong Choksuchat, 
											